NUTF2

gene
On this page

Also known as NTF2PP15

Summary

NUTF2 (nuclear transport factor 2, HGNC:13722) is a protein-coding gene on chromosome 16q22.1, encoding Nuclear transport factor 2 (P61970). Mediates the import of GDP-bound RAN from the cytoplasm into the nucleus which is essential for the function of RAN in cargo receptor-mediated nucleocytoplasmic transport. It is a common-essential gene (DepMap: required in 99.3% of cancer cell lines).

This gene encodes a cytosolic factor that facilitates protein transport into the nucleus. The encoded protein is required for nuclear import of the small Ras-like GTPase, Ran which is involved in numerous cellular processes. This protein also interacts with the nuclear pore complex glycoprotein p62.

Source: NCBI Gene 10204 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 10 total
  • Druggable target: yes
  • Cancer dependency (DepMap): dependent in 99.3% of screened cell lines (common-essential)
  • MANE Select transcript: NM_005796

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13722
Approved symbolNUTF2
Namenuclear transport factor 2
Location16q22.1
Locus typegene with protein product
StatusApproved
AliasesNTF2, PP15
Ensembl geneENSG00000102898
Ensembl biotypeprotein_coding
OMIM605813
Entrez10204

Gene structure

Transcript identifiers

Ensembl transcripts: 26 — 25 protein_coding, 1 retained_intron

ENST00000219169, ENST00000567105, ENST00000568233, ENST00000568390, ENST00000568396, ENST00000569436, ENST00000570026, ENST00000587481, ENST00000700610, ENST00000700611, ENST00000700612, ENST00000700613, ENST00000700614, ENST00000700615, ENST00000899783, ENST00000899784, ENST00000899785, ENST00000899786, ENST00000899787, ENST00000939627, ENST00000939628, ENST00000939629, ENST00000939630, ENST00000939631, ENST00000939632, ENST00000969121

RefSeq mRNA: 5 — MANE Select: NM_005796 NM_001322038, NM_001322039, NM_001322040, NM_001322041, NM_005796

CCDS: CCDS10848

Canonical transcript exons

ENST00000219169 — 5 exons

ExonStartEnd
ENSE000010477726784693367846985
ENSE000036017956786834067868411
ENSE000036514736786510267865229
ENSE000039803316787080067872567
ENSE000039803326786850167868599

Expression profiles

Bgee: expression breadth ubiquitous, 233 present calls, max score 97.25.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 190.4099 / max 809.1524, expressed in 1828 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
154683166.10761825
15468412.87401780
1546829.44501792
1546851.4328915
1546810.5505323

Top tissues by expression

250 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ascending aortaUBERON:000149697.25gold quality
hindlimb stylopod muscleUBERON:000425297.25gold quality
thoracic aortaUBERON:000151597.24gold quality
popliteal arteryUBERON:000225097.18gold quality
tibial arteryUBERON:000761097.18gold quality
aortaUBERON:000094797.12gold quality
left coronary arteryUBERON:000162697.01gold quality
C1 segment of cervical spinal cordUBERON:000646996.99gold quality
descending thoracic aortaUBERON:000234596.96gold quality
arteryUBERON:000163796.95gold quality
right coronary arteryUBERON:000162596.93gold quality
anterior cingulate cortexUBERON:000983596.78gold quality
stromal cell of endometriumCL:000225596.76gold quality
embryoUBERON:000092296.70gold quality
ganglionic eminenceUBERON:000402396.70gold quality
lower esophagus muscularis layerUBERON:003583396.57gold quality
lower esophagusUBERON:001347396.56gold quality
hypothalamusUBERON:000189896.49gold quality
amygdalaUBERON:000187696.48gold quality
coronary arteryUBERON:000162196.44gold quality
esophagogastric junction muscularis propriaUBERON:003584196.44gold quality
ventricular zoneUBERON:000305396.39gold quality
monocyteCL:000057696.26gold quality
smooth muscle tissueUBERON:000113596.26gold quality
leukocyteCL:000073896.21gold quality
gastrocnemiusUBERON:000138896.21gold quality
right adrenal gland cortexUBERON:003582796.20gold quality
skin of abdomenUBERON:000141696.19gold quality
right atrium auricular regionUBERON:000663196.19gold quality
body of uterusUBERON:000985396.19gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-7303no826.32
E-MTAB-8060no143.55
E-ANND-3no0.00

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): MYC

miRNA regulators (miRDB)

56 targeting NUTF2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4481100.0066.421669
HSA-MIR-9-5P100.0072.282361
HSA-MIR-4673100.0066.641490
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-365899.9673.874379
HSA-MIR-464899.9167.00710
HSA-MIR-76599.8468.242442
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-3156-3P99.7666.72939
HSA-MIR-11181-3P99.7566.382205
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-197699.7465.481127
HSA-MIR-4802-3P99.7270.131273
HSA-MIR-494-3P99.7071.452795
HSA-MIR-6715B-5P99.6469.631420
HSA-MIR-182799.6368.573265
HSA-MIR-1287-3P99.6366.93492
HSA-MIR-29899.6367.561916
HSA-MIR-891B99.5969.811083
HSA-MIR-211399.5871.221521
HSA-MIR-18A-3P99.5665.681092
HSA-MIR-426999.5569.891373
HSA-MIR-510-3P99.5470.062965
HSA-MIR-486-3P99.5166.821901
HSA-MIR-548G-3P99.4868.672159
HSA-MIR-1213199.4868.721673

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 99.3% of screened cell lines, common-essential.

Literature-anchored findings (GeneRIF, showing 9)

  • A nuclear pore binding site was studied on a mutated NTF2 protein. (PMID:15522285)
  • Results report that NTF2 and Ran control nuclear import of the filamentous actin capping protein CapG. (PMID:18266911)
  • NTF2 is a potential mediator of retinal vasculature integrity. (PMID:19404486)
  • Data suggest actin accumulation in senescent cells is due to the failure of RanGTP restoration with ATP deficiency and NTF2 accumulation, resulting in decreased actin export via Exp6 inactivation. (PMID:21195711)
  • Nucleocytoplasmic translocation of NTF2 is regulated in mammalian cells. (PMID:22880006)
  • Binding of Ran to NTF2 is required for NTF2 to inhibit nuclear expansion and import of large cargo molecules. (PMID:26823604)
  • These results showed that BLM enters the nucleus via the importin beta1, RanGDP and NTF2 dependent pathway, demonstrating for the first time the nuclear trafficking mechanism of a DNA helicase. (PMID:29017749)
  • DNA-Origami NanoTrap for Studying the Selective Barriers Formed by Phenylalanine-Glycine-Rich Nucleoporins. (PMID:34324340)
  • Nuclear Transport Factor 2 (NTF2) suppresses WM983B metastatic melanoma by modifying cell migration, metastasis, and gene expression. (PMID:34880267)

Cross-species orthologs

8 orthologs

OrganismSymbolGene ID
danio_rerionutf2ENSDARG00000056531
mus_musculusNutf2ENSMUSG00000008450
mus_musculusNutf2-ps1ENSMUSG00000071497
rattus_norvegicusNutf2l1ENSRNOG00000018945
rattus_norvegicusAABR07018058.1ENSRNOG00000057750
drosophila_melanogasterNtf-2FBGN0031145
drosophila_melanogasterNtf-2rFBGN0032680
caenorhabditis_elegansran-4WBGENE00004305

Paralogs (2): NXT2 (ENSG00000101888), NXT1 (ENSG00000132661)

Protein

Protein identifiers

Nuclear transport factor 2P61970 (reviewed: P61970)

Alternative names: Placental protein 15

All UniProt accessions (7): P61970, A0A8V8TPY3, A0A8V8TR25, A0A8V8TR28, A0A8V8TRD3, B4DEQ2, H3BRV9

UniProt curated annotations — full annotation on UniProt →

Function. Mediates the import of GDP-bound RAN from the cytoplasm into the nucleus which is essential for the function of RAN in cargo receptor-mediated nucleocytoplasmic transport. Thereby, plays indirectly a more general role in cargo receptor-mediated nucleocytoplasmic transport. Interacts with GDP-bound RAN in the cytosol, recruits it to the nuclear pore complex via its interaction with nucleoporins and promotes its nuclear import.

Subunit / interactions. Homodimer. Interacts with RAN (GDP-bound form); the interaction is direct and regulates RAN nuclear import. Interacts with the nucleoporins NUP54, NUP58 and NUP62 (via FG repeats); recruits NUTF2 to the nuclear pore complex a step required for NUTF2-mediated GDP-bound RAN nuclear import. Interacts with CAPG; mediates its nuclear import.

Subcellular location. Cytoplasm. Cytosol. Nucleus outer membrane. Nucleus. Nuclear pore complex. Nucleus inner membrane. Nucleoplasm.

RefSeq proteins (5): NP_001308967, NP_001308968, NP_001308969, NP_001308970, NP_005787* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002075NTF2_domDomain
IPR018222Nuclear_transport_factor_2_eukDomain
IPR032710NTF2-like_dom_sfHomologous_superfamily
IPR045875NTF2Family

Pfam: PF02136

UniProt features (14 total): strand 6, helix 3, mutagenesis site 2, chain 1, domain 1, modified residue 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
1GY5X-RAY DIFFRACTION2.3

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P61970-F195.290.93

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 4

Mutagenesis-validated functional residues (2):

PositionPhenotype
42no effect on localization to the nucleoplasm.
124no effect on localization to the nucleoplasm.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 209 (showing top): MYAATNNNNNNNGGC_UNKNOWN, E2F_Q4_01, chr16q22, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, KAAB_FAILED_HEART_ATRIUM_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, RACCACAR_AML_Q6, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOMF_GTPASE_BINDING, GGAMTNNNNNTCCY_UNKNOWN, CAGCTG_AP4_Q5, PUJANA_CHEK2_PCC_NETWORK, GOBP_NUCLEAR_TRANSPORT, AAACCAC_MIR140

GO Biological Process (6): protein import into nucleus (GO:0006606), protein export from nucleus (GO:0006611), mRNA transport (GO:0051028), protein localization to nuclear pore (GO:0090204), nucleocytoplasmic transport (GO:0006913), protein transport (GO:0015031)

GO Molecular Function (5): structural constituent of nuclear pore (GO:0017056), small GTPase binding (GO:0031267), identical protein binding (GO:0042802), nuclear import signal receptor activity (GO:0061608), protein binding (GO:0005515)

GO Cellular Component (11): nuclear inner membrane (GO:0005637), nuclear outer membrane (GO:0005640), nucleoplasm (GO:0005654), cytosol (GO:0005829), nuclear membrane (GO:0031965), nuclear pore central transport channel (GO:0044613), extracellular exosome (GO:0070062), nucleus (GO:0005634), nuclear pore (GO:0005643), cytoplasm (GO:0005737), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
intracellular protein transport2
import into nucleus2
nuclear pore2
nuclear membrane2
nuclear envelope2
nuclear protein-containing complex2
protein localization to nucleus1
establishment of protein localization to organelle1
nuclear export1
RNA transport1
protein localization to nuclear envelope1
nuclear transport1
transport1
intracellular protein localization1
establishment of protein localization1
structural molecule activity1
nucleocytoplasmic transport1
GTPase binding1
protein binding1
nucleocytoplasmic carrier activity1
binding1
organelle inner membrane1
organelle outer membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
nuclear lumen1
cytoplasm1
nucleus1
organelle membrane1
extracellular vesicle1
intracellular membrane-bounded organelle1
intracellular anatomical structure1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

168 interactions, top by confidence:

ABTypeScore
RANNUTF2psi-mi:“MI:0915”(physical association)0.890
NUTF2RANpsi-mi:“MI:0407”(direct interaction)0.890
RANNUP153psi-mi:“MI:0914”(association)0.790
NUP62NUTF2psi-mi:“MI:0915”(physical association)0.780
NUTF2NUP62psi-mi:“MI:0915”(physical association)0.780
NUTF2NUTF2psi-mi:“MI:0915”(physical association)0.670
NUTF2NUTF2psi-mi:“MI:0407”(direct interaction)0.670
CDKN1BKPNA3psi-mi:“MI:0915”(physical association)0.580
NUTF2SPATC1Lpsi-mi:“MI:0915”(physical association)0.560
NUTF2BRWD1psi-mi:“MI:0915”(physical association)0.560
NUTF2YAF2psi-mi:“MI:0915”(physical association)0.560
NUTF2THAP3psi-mi:“MI:0915”(physical association)0.560
NUTF2TLE5psi-mi:“MI:0915”(physical association)0.560
NUTF2LENG1psi-mi:“MI:0915”(physical association)0.560
NUTF2CHCHD3psi-mi:“MI:0915”(physical association)0.560
NUTF2KHDC4psi-mi:“MI:0915”(physical association)0.560
NUTF2TEX35psi-mi:“MI:0915”(physical association)0.560
NUTF2ZMAT2psi-mi:“MI:0915”(physical association)0.560
NUTF2psi-mi:“MI:0915”(physical association)0.560

BioGRID (152): NUTF2 (Two-hybrid), NUTF2 (Two-hybrid), NUP62 (Two-hybrid), NUTF2 (Affinity Capture-RNA), NUTF2 (Affinity Capture-RNA), NUTF2 (Affinity Capture-RNA), NUP62 (Reconstituted Complex), AP2A1 (Co-fractionation), AP2A2 (Co-fractionation), APOA1BP (Co-fractionation), CTH (Co-fractionation), GPX4 (Co-fractionation), HINT1 (Co-fractionation), NUTF2 (Co-fractionation), NUTF2 (Co-fractionation)

ESM2 similar proteins: A6QNX3, B2GV77, P09851, P20936, P50904, P61970, P61971, P61972, Q1JP79, Q29425, Q2KI42, Q2KIW0, Q2TBL9, Q32KP9, Q3UNA4, Q4R4K5, Q4R5H6, Q5E9J4, Q5F415, Q5FVJ7, Q5R8G4, Q5R8I6, Q5RB36, Q5RES2, Q5RKN4, Q5ZLH0, Q6PC62, Q8BG32, Q8BUH1, Q8IUI8, Q8K0F1, Q8MJJ1, Q92747, Q93034, Q99PD4, Q9CQC8, Q9CZQ9, Q9D5V5, Q9DAI2, Q9ES56

Diamond homologs: O42242, P33331, P61970, P61971, P61972, P87102, Q10100, Q21735, Q32KP9, Q5R8G4, Q6BWC0, Q6CC82, Q6CQX4, Q6FRC6, Q75AA5, Q8NJ52, Q96VN3, Q9C7F5, Q9FZK4, Q9P926, Q9XJ54, Q86HW7, P0CAN8, Q9FME2, Q5ZLH0, P97855, Q13283, Q32LC7, Q5RB87, Q9V3H8, O94260, Q9U757, B2GV77, Q3UNA4

SIGNOR signaling

1 interactions.

AEffectBMechanism
NUTF2“up-regulates activity”NUP62binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 63 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
NEP/NS2 Interacts with the Cellular Export Machinery544.4×1e-05
Nuclear import of Rev protein543.1×1e-05
Rev-mediated nuclear export of HIV RNA540.7×1e-05
NS1 Mediated Effects on Host Pathways536.6×2e-05
SUMOylation of DNA replication proteins531.8×2e-05
tRNA processing in the nucleus525.2×7e-05
ISG15 antiviral mechanism519.3×1e-04
HCMV Late Events512.6×5e-04

GO biological processes:

GO termPartnersFoldFDR
protein import into nucleus617.3×5e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

10 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

688 predictions. Top by Δscore:

VariantEffectΔscore
16:67865230:G:GGdonor_gain1.0000
16:67868334:TTTCA:Tacceptor_loss1.0000
16:67868335:TTCAG:Tacceptor_loss1.0000
16:67868336:TCAG:Tacceptor_loss1.0000
16:67868337:CAGAT:Cacceptor_loss1.0000
16:67868338:AGAT:Aacceptor_loss1.0000
16:67868339:G:Aacceptor_loss1.0000
16:67868408:GTCT:Gdonor_gain1.0000
16:67868412:G:GGdonor_gain1.0000
16:67868416:G:GGdonor_gain1.0000
16:67868500:GA:Gacceptor_gain1.0000
16:67868500:GAGCC:Gacceptor_gain1.0000
16:67868598:AG:Adonor_loss1.0000
16:67868599:GGTAA:Gdonor_loss1.0000
16:67868600:G:Tdonor_loss1.0000
16:67870797:TA:Tacceptor_loss1.0000
16:67870798:A:AGacceptor_gain1.0000
16:67870798:A:Cacceptor_loss1.0000
16:67870798:AGGC:Aacceptor_gain1.0000
16:67870799:G:GGacceptor_gain1.0000
16:67870799:GGC:Gacceptor_gain1.0000
16:67870799:GGCG:Gacceptor_gain1.0000
16:67865191:T:Gdonor_gain0.9900
16:67868338:A:AGacceptor_gain0.9900
16:67868339:G:GGacceptor_gain0.9900
16:67868339:GATT:Gacceptor_gain0.9900
16:67868407:TGTCT:Tdonor_gain0.9900
16:67868408:GTCTG:Gdonor_gain0.9900
16:67868409:TCT:Tdonor_gain0.9900
16:67868409:TCTGT:Tdonor_gain0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000000842 (16:67853556 T>C), RS1000082581 (16:67845853 C>T), RS1000108866 (16:67856514 G>A,T), RS1000112117 (16:67860436 G>A,T), RS1000150548 (16:67863379 AGCTG>A), RS1000176513 (16:67870929 G>T), RS1000306697 (16:67870717 AT>A,ATT), RS1000362521 (16:67856957 G>A), RS1000413714 (16:67866969 A>C,G,T), RS1000482398 (16:67861592 T>C), RS1000547586 (16:67860170 G>A), RS1000748422 (16:67861967 G>C), RS1000832563 (16:67848251 C>T), RS1001193571 (16:67856490 C>A), RS1001232055 (16:67872067 G>T)

Disease associations

OMIM: gene MIM:605813 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST002539_84Schizophrenia2.000000e-08
GCST006803_42Schizophrenia4.000000e-08
GCST010002_113Refractive error2.000000e-14

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6067085 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
8.66Kd2.171nMCHEMBL3752910
8.66ED502.171nMCHEMBL3752910
6.38Kd419.2nMCHEMBL5653589
6.38ED50419.2nMCHEMBL5653589

PubChem BioAssay actives

2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2148908: Binding affinity to human NUTF2 incubated for 45 mins by Kinobead based pull down assaykd0.0022uM
4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2148908: Binding affinity to human NUTF2 incubated for 45 mins by Kinobead based pull down assaykd0.4192uM

CTD chemical–gene interactions

35 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases expression, increases expression3
Valproic Acidaffects cotreatment, decreases expression, increases expression3
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideincreases expression, decreases expression, affects cotreatment2
Tretinoindecreases expression2
aristolochic acid Iincreases expression1
bisphenol Fincreases expression1
nobiletindecreases expression, decreases reaction1
sodium arsenatedecreases expression, decreases reaction1
sodium arsenitedecreases expression1
cobaltous chloridedecreases expression1
ochratoxin Aincreases expression1
tamibaroteneaffects expression1
microcystin RRdecreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
K 7174decreases expression1
dorsomorphinaffects cotreatment, decreases expression1
LDN 193189affects cotreatment, increases expression1
bisphenol AFincreases expression1
Arsenicaffects methylation1
Cisplatinincreases expression1
Diazinonincreases methylation1
Doxorubicindecreases expression1
Hydrogen Peroxideaffects expression1
Ivermectindecreases expression1
Seleniumincreases expression1
Smokedecreases expression1
Theophyllineincreases expression1
Tobacco Smoke Pollutionaffects expression1
Vitamin Eincreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5651950BindingBinding affinity to human NUTF2 incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.